Tennessee · 114th Regular Session (2025-2026) · Bill

SB 907: Taxes, Business - As introduced, exempts from business tax, receipts from the sale of a prescription drug or medicine with a cost for a 30-day equivalent supply that exceeds the medicare cost threshold for 2025 plan years and services necessary for proper preparation, storage, handling, administration, patient education, or post-sale monitoring of such exempted drugs or medicines. - Amends TCA Title 67, Chapter 4, Part 7.

In committee Last action April 20, 2026: Placed on Senate Finance, Ways, and Means Committee calendar for 4/21/2026

Plain-language summary

SB 907 is a bill introduced in the Tennessee Senate on February 5, 2025. According to its official title, it concerns: Taxes, Business - As introduced, exempts from business tax, receipts from the sale of a prescription drug or medicine with a cost for a 30-day equivalent supply that exceeds the medicare cost threshold for 2025 plan years and services necessary for proper preparation, storage, handling, administration, patient education, or post-sale monitoring of such exempted drugs or medicines. - Amends TCA Title 67, Chapter 4, Part 7. Primary sponsor: Ferrell Haile (Republican). Most recent recorded action (April 20, 2026): Placed on Senate Finance, Ways, and Means Committee calendar for 4/21/2026.

Sponsors

Primary sponsor: Ferrell Haile (Republican).